ACI Anti-Corruption, Fraud, and Global Compliance for Life Sciences Conference 2026

Morrison Foerster is proud to sponsor the upcoming American Conference Institute (ACI) Anti-Corruption, Fraud, and Global Compliance for Life Sciences Conference 2026. MoFo partner B. Chen Zhu will moderate a panel titled “China’s Corruption Crackdown and Implementation of HCP, Third Party and Clinical Trial Guidelines: A New Era of Mitigating Bribery, Procurement, Data Security and More Risks.”

As China’s healthcare and life sciences sector enters a new phase of regulatory reform and global integration, this panel joined by Lamia Matta (Senior Director, ABAC & Investigations, Cook Medical) and Linda Nguyen (Executive Director, Assistant General Counsel, Regeneron) will explore how companies can navigate heightened enforcement and evolving compliance expectations.

Discussion topics will include:

• Mitigating commercial bribery risks in drug and medical device procurement
• Transparency in healthcare professional (HCP) engagement
• Monitoring online healthcare, genetic testing, and insurance systems
• Best practices for the flow of sensitive data and business operations

This leading ACI conference brings together senior legal, compliance, and business professionals from across the life sciences sector to address the latest developments in anti-corruption enforcement, regulatory expectations, and compliance best practices.

For more information, please view the event agenda.